Nifty Pharma

A Healthy Choice for Capturing Growth in the Indian Pharmaceutical Industry

As of Nov 05, 2026, the PE ratio is 44.84 and the PB ratio is 5.20

Compare in Table
Full history is available on Pro. Upgrade to Pro.

Understand the movement. Plan the amount.

Risk & return tools

How these tools work ↗

Research tools for Nifty Pharma. Closing data through 2026-11-05; history starts 2011-01-31.

20-session closing breakout

20-session Closing Breakout

The latest closing level is above every close in the preceding 20 available sessions. It identifies recent closing strength.

Read the guide

Breakout active

Latest close: 27,607.60 · Previous 20-session highest close: 27,333.45.

Today is excluded from the reference level. A breakout can fail; it is a research prompt.

ATR volatility (14)

ATR Volatility

ATR measures the size of daily price ranges, including gaps from the previous close. It measures movement, not its direction.

Read the guide

Unavailable

ATR needs 15 consecutive imported sessions with daily highs, lows and closes.

Measures movement, not direction. Index points are not an ETF’s price or a guaranteed stop distance.

Drawdown in rupees

Drawdown in Rupees

Translate a historical percentage decline into an example rupee loss. This makes the size of a decline easier to understand.

Read the guide

Enter a hypothetical amount at a peak to see the effect of a repeat of a recorded decline.

Historical decline7.52%
Example loss₹75.19
Amount after decline₹924.81
Gain needed to recover8.13%

Historical illustration, not a future loss forecast or a maximum-loss limit. Uses available closes; missing sessions can understate declines. Intraday declines, dividends, fund costs and taxes are excluded. Your amount stays in this browser.

Rolling-return comparison

Rolling-return Comparison

Compare many historical investment windows instead of relying on a single start date. See the worst, median and best observed annualized returns.

Read the guide

Annualized returns of the stored index series across monthly historical windows. Compare the range of outcomes over different holding periods.

Comparisons use matching start and end dates. A shorter history can reduce the number of comparable windows.

1-year windows

Worst CAGR
-24.21%
Median CAGR
11.63%
Best CAGR
71.07%
Losing windows
33.52%

179 overlapping windows ending 2012-01-31 to 2026-11-05.

Matched median CAGR · 167 windows

Nifty Pharma: 13.63%

Nifty 50: 10.26%

3-year windows

Worst CAGR
-13.04%
Median CAGR
14.63%
Best CAGR
36.61%
Losing windows
21.29%

155 overlapping windows ending 2014-01-31 to 2026-11-05.

Matched median CAGR · 119 windows

Nifty Pharma: 15.29%

Nifty 50: 10.98%

5-year windows

Worst CAGR
-10.99%
Median CAGR
8.79%
Best CAGR
25.40%
Losing windows
13.08%

130 overlapping windows ending 2016-02-29 to 2026-11-05.

Matched median CAGR · 71 windows

Nifty Pharma: 4.77%

Nifty 50: 11.71%

10-year windows

Worst CAGR
5.20%
Median CAGR
8.42%
Best CAGR
12.33%
Losing windows
0.00%

70 overlapping windows ending 2021-02-26 to 2026-11-05.

Matched median CAGR · 11 windows

Nifty Pharma: 11.28%

Nifty 50: 11.13%

Each month uses its last observed close; the latest month may be incomplete. Start observations are on or before the calendar anniversary within seven days. Windows containing gaps over 14 days are excluded. Returns are annualized using actual elapsed days. Overlapping windows are not independent trials or future probabilities. Price-index series exclude dividends. Fund costs and taxes are excluded; these are not fund or SIP returns. Different index methods can affect comparisons.

Index Report

Easy-to-read, rules-based summary. Educational only.

1) Index Snapshot (1-minute read)

Nifty Pharma is at 27,607.60 as of Nov 05, 2026. 1Y CAGR is 21.69%. It is 0.00% below its recent peak. Current valuation: PE 44.84, PB 5.20.

As of
Nov 05, 2026
Current Value
27,607.60
PE / PB
44.84 / 5.20
Dividend Yield
0.54%
1Y CAGR
21.69%
3Y CAGR
-
5Y CAGR
-
Volatility (1Y)
14.68%
Drawdown from Peak
0.00%

4) Sector Contribution Breakdown

Based on constituent counts (weights not available).

Healthcare
100.00%

5) Risk Signals

  • Volatility is low (14.68%). Moves are calmer.
  • Index is near its recent peak (drawdown 0.00%).
  • Valuation is elevated vs history.

Signals are descriptive, not predictions.

6) Action Guidance

SIP
Maintain

Maintain SIP contributions for long-term discipline.

Lump-sum
Avoid

Avoid lump-sum entries at elevated valuations.

Rules-based guidance for long-term investors. Not a buy/sell call.

7) Index vs Inflation vs FD

Inflation and FD rates are not configured yet.

AI Insights

Explore dated reports covering this index’s past performance, news and possible scenarios.

PRO includes the first index published each India-time month. PRIME includes every published index and edition.

View reports and history →

Supporting Guides

Intent-focused pages connected to this index.

Technical Signals

Select a signal to see matching indices, or tap ? to learn what it means.

Golden Cross Active
Golden Cross Active

The medium-term average is above the long-term average, and the index is above its long-term average. This describes a positive trend backdrop.

Read the guide

Historical vs. Current Market

Compare its historical behavior with the current market environment to gain insights into potential trends.

GreedyFearCurrent Market Nov 05, 2026
PEPBDIVPointsPEPBDIVPointsFall(%)~PEPBDIVMRI
Level
Jan 16, 2020Mar 24, 2020~44.845.200.54
26.323.230.638203.1020.422.530.826611.05-19.41

70.36

119.59

60.99

105.53

14.29

34.15

13
Apr 09, 2015Mar 24, 2020
55.809.330.4813545.9020.422.530.826611.05-51.2

19.64

119.59

44.27

105.53

12.5

34.15

13

Recent Performance

Analyze the recent performance of the Nifty Pharma, including its recent highs and lows

Recent HighRecent LowCurrent Market Nov 05, 2026
PEPBDIVPointsPEPBDIVPointsFall(%)~PEPBDIVPoints
Nov 05, 2026Nov 05, 2026~Nov 05, 2026
44.845.200.5427607.6044.845.200.5427607.600

44.845.200.5427607.60 (0% )

Performance

Past performance returns (%) of the index

#1D1W1M3M6M1Y3Y5Y7Y10Y15Y
Nifty Pharma17.783.496.4119.1425.85-----

Fundamentals

Nifty Pharma

PEPBDiv
44.845.200.54

Exchange Traded Funds (ETF)

Available ETFs tracking this index

Exchange Trade Fund ( ETF )
Name of the ETFExpense
Nippon India Nifty Pharma ETF0.21

Index Companies

Companies included in this index

Companies
Name of the companyIndustrySymbol
Abbott India Ltd.HealthcareABBOTINDIA
Alembic Pharmaceuticals Ltd.HealthcareAPLLTD
Alkem Laboratories Ltd.HealthcareALKEM
Aurobindo Pharma Ltd.HealthcareAUROPHARMA
Biocon Ltd.HealthcareBIOCON
Cipla Ltd.HealthcareCIPLA
Divi's Laboratories Ltd.HealthcareDIVISLAB
Dr. Reddy's Laboratories Ltd.HealthcareDRREDDY
Gland Pharma Ltd.HealthcareGLAND
Glenmark Pharmaceuticals Ltd.HealthcareGLENMARK
Granules India Ltd.HealthcareGRANULES
Ipca Laboratories Ltd.HealthcareIPCALAB
Laurus Labs Ltd.HealthcareLAURUSLABS
Lupin Ltd.HealthcareLUPIN
NATCO Pharma Ltd.HealthcareNATCOPHARM
Pfizer Ltd.HealthcarePFIZER
Strides Pharma Science Ltd.HealthcareSTAR
Sun Pharmaceutical Industries Ltd.HealthcareSUNPHARMA
Torrent Pharmaceuticals Ltd.HealthcareTORNTPHARM
Zydus Lifesciences Ltd.HealthcareZYDUSLIFE

About

The NIFTY Pharma Index serves as a vital benchmark for the Indian pharmaceutical sector, tracking the performance of the top 20 pharmaceutical companies listed on the National Stock Exchange of India (NSE). These companies encompass various segments of the industry, from established giants like Sun Pharmaceutical and Divi's Lab to innovative players like Dr. Reddy's and Cipla.

Portfolio Characteristics

MethodologyPeriodic capped free-float
No. of Constituents20
Launch Date2016-07-01
Calculation FrequencyReal-Time
Index RebalancingSemi - Annually